vimarsana.com

Latest Breaking News On - Company generates - Page 19 : vimarsana.com

Transcripts For KQEH Nightly Business Report 20151030

The day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he engineered a 25 billion sale to activeus. After unexpectedly taking the ceo job there sand

Transcripts For KQED Nightly Business Report 20151030

The day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he engineered a 25 billion sale to activeus. After unexpectedly taking the ceo job there sand

Transcripts For KTIV Mad Money 20151027

Suggesting Microsoft Might have some pull . Right now, nobody wants it. Nobody hates the surface. Wait a second, last week its been so popular. It is popular. Surface . Its not just the nfl, which is all surface all the time. Listen to the ceo, by ththway, all thososads on the football l games, people and monstersrslow each up endlessly, people refuse to link xbox to microsoft. Even though thth might make the darn. I know ive tataed my head off. They h he to break up skype, xbox, windows, or enterpriseiei cloud. Soft, call them that. Right now, microsoft the company is totally uncool. Microsoft the products are either cool or ret kro cool t. Problem is, microsoft doesnt seem to know it. Hey, sacha, in the black teeshirt, thats cool. The next time i see you, i will wear a plaque teeshirt with a tie. Its not a good stock. Its an absolutely good company. I think people are starting to like their products. Shh, some are good. Let me set the stage for another one, many people are rich. Shoc

Transcripts For KQED Nightly Business Report 20151030

Pfizer did turn negative late in the day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he engineered a 25 billion sale to activeus. After unexpecte

Transcripts For KWWL Mad Money 20151027

So why the heck cant mcdonalds throw itself around, too . Its the execution thats been the problem, not the unhealthy food, if it was food, why the heck is whole foods at a 52week low. If it were about nutrition, how about pepsico keeps churning higher because of the strength of junk food . Invite everyone over for the cowboysgiants game. I was happy someone lost. You think i had carrots and celery . I had some of those. Look, i own a mexican restaurant, its a pretty good darn salsa, people have been telling me for years the clock is ticking on frito lay. All i know, when i go shopping for the guy, i press them to bring oem anything else. Heres another story people simply cannot put their arms around. They cant believe, the corn popularity of microsoft devices. Im getting laughed at for suggesting Microsoft Might have right now, nobody wants it. Nobody hates the surface. Wait a second, last week its been so popular. It is popular. Why do i see people at the surface . Its not just the n

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.